|
|
Application value of MSCTU+CTA in the diagnosis of urological malignant tumor |
ZUO Kai-rong1 CHEN Li1 LI Lun-cheng1 LI Zheng-xiong1 DAI Hong1 ZHOU Yi1 LIU Yuan-bin2▲ |
1. Department of Radiology, the Second People′s Hospital of Jiangjin District in Chongqing City, Chongqing 402289,China;
2. Department of Radiology, the People′s Hospital of Qijiang District in Chongqing City, Chongqing 401420,China |
|
|
Abstract Objctive To investigate the aoolication value of multi-slice spiral computed tomography urography and computed tomography angiography (MSCTU+CTA) in the diagnosis of urological malignant tumor. Methods A total of 55 participants with urological malignant tumor who were examined by MSCTU + CTA and ultrasound (US) in our hospital from January 2014 to September 2019 were selected as the study objects. Imaging was analyzed retrospectively,and the diagnostic efficacy of the two groups was evaluated according to the surgical and pathological results. Results Within the 55 malignant tumor, there were 18 cases with renal cell carcinomas, 3 cases with renal pelvic cancer, 2 cases with ureteral cancer, and 32 cases with bladder cancer. A total of 42 cases were diagnosed correctly, 8 cases were misdiagnosed, and 5 cases were missed by US, the accuracy of location diagnosis was 90.90% (50/55), and that of qualitative diagnosis was 76.36% (42/55). As for MSCTU+CTA, there were 50 cases diagnosed correctly, 3 cases were misdiagnosed and 2 cases were missed, the accuracy of location diagnosis was 96.36% (53/55), and that of qualitative diagnosis was 90.90% (50/55). The diagnostic accuracy of MSCTA+CTU was significantly higher than US, and the difference was statistically significant (P<0.05). Conclusion Both MSCTU+CTA and US play important role in the diagnosis of urological malignant tumor. MSCTU+CTA is better than US in diagnostic accuracy and has significant value for clinical application.
|
|
|
|
|
[1] |
李清福,罗晓丽.泌尿系统恶性肿瘤的CT 诊断及其病理对照研究[J].中国肿瘤临床与康复,2014,21(9):1065-1067.
|
[2] |
Huguet J.Transitional cell carcinoma of the upper urinary tract after cystectomy[J].Arch Esp Urol,2012,65(2):227-236.
|
[3] |
Moch H,Cubilla AL,Humphrey PA,et al.The 2016 WHO Classifi-cation of Tumours of the Urinary System and Male Genital Organs-Part A:Renal,Penile,and Testicular Tumours[J].Eur Urol,2016,70(1):93-105.
|
[4] |
Humphrey PA,Moch H,Cubilla AL,et al.The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B:Prostate and Bladder Tumours[J].Eur Urol,2016,70(1):106-119.
|
[5] |
赵辉.多排螺旋CT 早期增强扫描对肾癌诊断价值[J].世界最新医学信息文摘,2019,19(89):175-176.
|
[6] |
李立,钱伟军,徐建军.不典型肾癌MSCT 诊断与鉴别诊断[J].深圳中西医结合杂志,2017,15(3):343-344.
|
[7] |
谭迎杰.膀胱癌CT 尿路成像的特点及影像学价值分析[J].现代医用影像学杂志,2019,28(8):1734-1736.
|
[8] |
陈运贵.多层螺旋CT 三期增强扫描对膀胱癌的诊断价值研究[J].中国CT 和MRI 杂志,2019,17(3):102-104.
|
[9] |
李涵默,丁冠融.多层螺旋CT 三维成像技术在膀胱癌诊断中的临床价值[J].中国临床研究,2019,32(1):68-70.
|
[10] |
高白,姚胜银,王嫦华,等.MSCT 增强扫描与超声造影对膀胱癌术前分期的诊断价值[J].中国CT 和MRI 杂志,2019,17(4):105-108.
|
[11] |
刘彦,曹志刚,何中,等.超声、CT 检查对肾肿瘤诊断价值研究[J].中国CT 和MRI 杂志,2017,15(1):92-94.
|
[12] |
康丽丽,陈俊宏,何雪婷,等.CT 预测肌层浸润性膀胱尿路上皮癌盆腔淋巴结转移的回顾性研究[J].中国临床解剖学杂志,2019,37(4):431-435.
|
[13] |
王萍,刘健,岳文胜,等.超声造影与CT 对膀胱癌术前分期的诊断价值比较[J].山东医药,2018,58(14):72-74.
|
[14] |
王振潮,宋殿宾,徐辉.术前辅助CT 血管成像联合CT 尿路成像检查对肾癌患者后腹腔镜肾部分切除术疗效的影响[J].癌症进展杂志,2019,17(20):2392-2394.
|
[15] |
李胜军,王义欢,夏亮.多层螺旋CT 应用于肾癌诊断中的临床价值研究[J].中国CT 和MRI 杂志,2017,15(1):89-91.
|
[16] |
陈娟,李思江,蒲军,等.输尿管癌的早期诊断及影像学特点[J].检验医学与临床,2018,15(1):73-76.
|
[17] |
明康,杨利霞,符忠祥,等.64 排螺旋CT 图像后处理技术对膀胱癌的诊断价值研究[J].中国CT 和MRI 杂志,2019,17(11):108-110.
|
[18] |
唐辉.多层螺旋CT 成像在泌尿系统疾病诊断中的应用进展[J].中国当代医药,2018,25(35):19-21.
|
|
|
|